BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
What was lobbied
18 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Medicaid Rebates Dual Eligibles S. 365: Budget Control Act of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Medicare Part D Prescription Drug Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Clean Air and Water (quality) CAW
Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| DANA MAURICE O'BRIEN | — |
Fuel/Gas/Oil FUE
Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting Biofuels Next Generation Incentives : Farm Bill Reauthorization Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight Biorefineries Next Generation Incentive Tax Credits Bio-based Products Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Tax Credit USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Homeland Security HOM
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Federal Supply Schedule Access During Emergencies Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization Act of 2011 International Biosecurity Policies Biologics and Toxins Weapons Convention
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Trade (domestic/foreign) TRD
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Export Registrations for Products with Expired Patents Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Discussions with EU on Animal Cloning APEC Agricultural Biotechnology Discussions EU Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization TransPacific Partnership Sanitary and Phytosanitary Issues Data and Intellectual Property Protections for Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| MELISSA BOWIE | — |
| JOSEPH DAMOND New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| MATTHEW O'MARA | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Agriculture AGR
USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Biomass Crop Assistance Program Funding H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Farm Bill Reauthorization EPA Regulations on Agricultural Biotechnology EPA Notice on PIP Data Requirements Reauthorization and Implementation of Pesticide Registration Improvement Act Biotechnology Stewardship International Regulatory Synchronization Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2011 H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Export Registrations for Products with Expired Patents Labeling of Genetically Engineered Crops U.S. Government Policy TransPacific Partnership Sanitary and Phytosanitary Issues Adventitious Presence (Low Level Presence) U.S. Low Level Presence Policy Funding for the USDA (Office of General Counsel , Biotechnologies Regulatory Services (BRS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Foreign Agricultural Biotechnology Laws and Regulations Low-Level Presence Foreign Government Policies China Biotechnology Regulations Discussions with EU on Animal Cloning APEC Agricultural Biotechnology Discussions EU Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| JOSEPH DAMOND New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW O'MARA | — |
Taxation/Internal Revenue Code TAX
Biorefineries Next Generation Incentive Tax Credits Bio-based Products Tax Credit Therapeutic Discovery Project Tax Credit Extension Biofuels Investment Tax Credit Options Biofuels Production Tax Credit Modification for Algae-based Biofuels Biofuels Production Tax Credit Extension Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 S. 1577: Greater Research Opportunities With Tax Help Act of 2011 Capital Formation Investment Incentives Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| CHARLES H FRITTS | — |
| SHELLY MUI-LIPNIK | — |
| DANA MAURICE O'BRIEN | — |
| MATTHEW SCHUMAKER | — |
| RINA SINGH | — |
| TOOSHAR SWAIN | — |
Copyright/Patent/Trademark CPT
Patent Reform Implementation of H.R. 1249: The America Invents Act of 2011 World Trade Organization Special 301 Submissions China Issues Finland Issues Russia Issues Genetic Resource Patent Disclosure Requirement World Intellectual Property Organization DNA Patenting and Licensing Rep. Wasserman Schultz Amendment to H.R. 1249: The America Invents Act of 2011 Bayh-Dole Act/Tech Transfer Bayh-Dole Act/Tech Transfer Commercialization of Federally Funded Research Initiative Domestic Manufacturing Requirement International IP Patent Law Harmonization TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| JOSEPH DAMOND New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| HANSJORG SAUER | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Health Issues HCR
TransPacific Partnership Data and Intellectual Property Protections for Pharmaceuticals Biosimilars Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Reporting of Physician Payments Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act Vaccine Access/Financing Adult Immunization Policies Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act 340B Drug Pricing Program Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act HRSA Implementation of Program Changes Federal Supply Schedule Access During Emergencies Expanded Access to Experimental Products Medicaid Rebates Dual Eligibles S 365: Budget Control Act of 2011 Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Diagnostics and Personalized Medicine Regulation and Oversight Therapeutic Discovery Project Tax Credit Extension Rare Pediatric & Tropical Disease Drug Development Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S. R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011 Reimbursement for Innovative Products Part B Physician-Administered Products Medicare Part D Prescription Drug Program International Biosecurity Policies Biologics and Toxins Weapons Convention
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO New | — |
| JOSEPH DAMOND New | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| ALAN EISENBERG | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| LILA FEISEE | — |
| CHARLES H FRITTS | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SHELLY MUI-LIPNIK | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
| ROY STANFORD ZWAHLEN | — |
Small Business SMB
Shareholder Reporting Threshold S. 1824/H.R. 2167: Private Company Flexibility and Growth Act of 2011 Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 H.R. 1425: Creating Jobs Through Small Business Innovation Act of 2011 H.R. 1540: National Defense Authorization Act for FY 2012 Sarbanes Oxley Section 404 (b) H.R. 3213: Small Company Job Growth and Regulatory Relief Act of 2011 S. 1933/H.R. 3606: Reopening American Capital Markets to Emerging Growth Companies Act of 2011 Therapeutic Discovery Project Tax Credit Extension Capital Formation Investment Incentives Expansion of Exemption Under SEC Regulation A S. 1544/H.R. 1070: The Small Company Capital Formation Act of 2011 Reform of SEC Regulation D S. 1831/H.R. 2940: Access to Capital for Job Creators Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| SHELLY MUI-LIPNIK | — |
| MATTHEW SCHUMAKER | — |
| TOOSHAR SWAIN | — |
| ANNA KATHERINE WEINSTEIN | — |
Medicare/Medicaid MMM
Medicaid Rebates Dual Eligibles S. 365: Budget Control Act of 2011 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| ANDREW EMMETT | — |
| JEANNE HAGGERTY | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Budget/Appropriations BUD
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Funding for the USDA (Office of General Counsel , Biotechnologies Regulatory Services (BRS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels, Foreign Agriculture Service) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H..R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Funding for Centers for Disease Control and Prevention Vaccine Programs S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Funding for National Institutes of Health Cures Acceleration Network National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Funding for Biomass Crop Assistance Program H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA BOWIE | — |
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Consumer Issues/Safety/Products CSP
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012 H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Drug Importation H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Labeling of Genetically Engineered Crops U.S. Government Policy Drug Safety and Review FDA Globalization Act (Discussion Draft) Prescription Drug User Fee Act (PDUFA) Reauthorization Regulatory Reforms for Innovative Products TREAT Act (Senate Discussion Draft) E-Pedigree and Anti-Counterfeiting Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine, Scientific Infrastructure) H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Drug Shortages S. 296: Preserving Access to Life-Savings Medicines Act of 2011 H.R. 2245: Preserving Access to Life Saving Medicines Act of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| MELISSA BOWIE | — |
| BRENT ALAN DELMONTE | — |
| SANDRA DENNIS | — |
| TOM DILENGE | — |
| DAVID EDWARDS | — |
| ANDREW EMMETT | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| ALYSON PUSEY | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| LAUREL TODD | — |
| ANNA KATHERINE WEINSTEIN | — |
Energy/Nuclear ENG
Climate Change Benefits of Biofuels and Bio-based Products Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Biogenic Carbon Emissions Accounting Biofuels Next Generation Incentives : Farm Bill Reauthorization Department of Defense Applications of Advanced Biofuels (Opposition to Section 526 Repeal) Investment Tax Credit Options Economic Growth Impact/Potential of Advanced Biofuels Biofuels Production Tax Credit Modification for Algae-based Biofuels DOE Loan Guarantees and Grants under the Energy Policy Act of 2005 (Implementation and Funding) Biofuels Production Tax Credit Extension Funding for Biofuels H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Fuels Standard Implementation of Energy Independence and Security Act of 2007 Regulatory Oversight Biorefineries Next Generation Incentive Tax Credits Bio-based Products Next Generation Incentives: Farm Bill Reauthorization Expansion of DOE and USDA Loan Guarantee Programs Tax Credit USDA BioPreferred Program Economic Growth Impact/Potential of Advanced Bio-based Products Funding for Bio-based Products H.R. 2219: Department of Defense Appropriations Act for FY 2012 H.R. 2354: The Energy and Water Appropriations Act for 2012 Renewable Chemicals New Production Tax Credit/Revisions to Existing Tax Credits S.847: The Safe Chemicals Act of 2011 (TSCA Reform Proposals)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATT CARR | — |
| SARAH THORNTON CASWELL | — |
| BRENT ALAN DELMONTE | — |
| CHARLES H FRITTS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
| RINA SINGH | — |
Food Industry (safety, labeling, etc.) FOO
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2011 H.R. 2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon Labeling of Genetically Engineered Crops U.S. Government Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Animals ANI
Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Genetically Engineered (GE) Animals Labeling FDA Approval S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012 H.R.2112: Consolidated and Further Continuing Appropriations Act of 2012 Amendment to Restrict FDA Approval of GE Salmon
| Lobbyist | Covered position, as disclosed |
|---|---|
| AB BASU | — |
| BRENT ALAN DELMONTE | — |
| DAVID EDWARDS | — |
| TRACEY LATURNER | — |
| DANA MAURICE O'BRIEN | — |
Medical/Disease Research/Clinical Labs MED
Funding for National Institutes of Health S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Rare Pediatric & Tropical Disease Drug Development Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 Cures Acceleration Network S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2012 National Center for Advancing Translational Sciences S.R. 1599: Departments of Labor, HHS, Education, and Related Agencies Appropriations for FY 2012 Biodefense Research, Development and Procurement HHS Countermeasures Review S. 1855: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHYLLIS ARTHUR | — |
| MELISSA BOWIE | — |
| KELLY CAPPIO New | — |
| BRENT ALAN DELMONTE | — |
| TOM DILENGE | — |
| ELIZABETH CARTIER ESHAM | — |
| JEANNE HAGGERTY | — |
| TRACEY LATURNER | — |
| SARA RADCLIFFE | — |
| MATTHEW SCHUMAKER | — |
| ANNA KATHERINE WEINSTEIN | — |
Science/Technology SCI
Research & Development Tax Credit Extension H.R. 942: American Research and Competitiveness Act of 2011 S. 1577: Greater Research Opportunities With Tax Help Act of 2011 Small Business Innovation and Research (SBIR) Program Reauthorization S.493: SBIR/STTR Reauthorization Act of 2011 H.R. 1425: Creating Jobs Through Small Business Innovation Act of 2011 H.R. 1540: National Defense Authorization Act for FY 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DELMONTE | — |
| ALAN EISENBERG | — |
| ELIZABETH CARTIER ESHAM | — |
| CHARLES H FRITTS | — |
| MATTHEW SCHUMAKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.